Penn Engineers secure Wellcome Leap contract for lipid nanoparticle research essential in delivery of RNA therapies
The multimillion-dollar contract with Wellcome Leap will help create “on-demand” manufacturing technology that can produce a range of RNA-based vaccines. The two-pronged project will use a design method that creates a barcode library of novel lipid nanoparticles (LNPs) with custom features, while the other will develop microfluidic chips for the precise manufacturing of these RNA-based therapies.
FULL STORY AT Penn Engineering Today →